AgNovos Healthcare

AgNovos Healthcare is developing a new therapy for osteoporosis, a debilitating bone disease that affects more than 200 million women worldwide. In patients with osteoporosis, the normal bone remodeling process is unbalanced. This imbalance leads to reduced bone mass and deterioration in bone quality, resulting in decreased bone strength and an increased risk of fractures. AgNovos' pioneering approach to treating osteoporosis is based on the experience of our founders during their clinical practice careers.The company has developed a treatment—OSSURETM LOEP® (Local OsteoEnhancement Procedure)—and conducted extensive preclinical and clinical studies on it. These studies show that OSSURE LOEP can immediately, substantially, and durably increase bone density and strength post-treatment.